Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank50
5Y CAGR-63.4%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

5Y CAGR
-63.4%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
20252.26%
202444.44%
2023-11.28%
2022-6.54%
2021641.89%
2020345.09%
20190.00%